Meridien Research /ID# 226224 — St. Petersburg, Florida

Meridien Research /ID# 226224 is a clinical research site located in St. Petersburg, Florida, United States 33709.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Meridien Research /ID# 226224 has participated in 1 clinical trials.

Therapeutic areas: Episodic Migraine.

Sponsors: Allergan.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Meridien Research /ID# 226224?

Meridien Research /ID# 226224 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Meridien Research /ID# 226224 conducted?

Meridien Research /ID# 226224 has 1 clinical trials on record. Their work covers Episodic Migraine.

Is Meridien Research /ID# 226224 accredited by Crixeo Health?

Meridien Research /ID# 226224 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Meridien Research /ID# 226224?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.